Sunday, 24 August 2008

Enobia Pharma Initiates Clinical Testing Of Enzyme Replacement Therapy To Treat Hypophosphatasia

div























Latest News For Bones / Orthopaedics
Research Indicates No Justification For Denying Obese Patients Knee Replacements
21 Aug 2008

Enobia Pharma Initiates Clinical Testing Of Enzyme Replacement Therapy To Treat Hypophosphatasia
21 Aug 2008

Predicting Injury Of Military Personnel And Athletes
21 Aug 2008

View more news...

Latest Videos for Bones
Osteoporosis and Psychology



Understanding the psychological challenges of osteoporosis - and knowing how to cope with them - ar important goals for all women with this disease. In this webcast, the emotional issues facing women with osteoporosis...


Living with Osteoporosis



No picture of osteoporosis is complete without an understanding of the personal impact this disease can have. And no one can express this impact better than someone who is living with the disease. Join us as we talk to Cecilia Johnson about the physical and emotional challenges of her 15-year...


View more videos...




Most Popular Categories



cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

















More info

Wednesday, 6 August 2008

Sony may bite on Spidey spinoff

Studio developing 'Venom,' quest new writers




With Heath Ledger's villainous Joker drawing attention and boxoffice dollars, Sony is moving forward with "Venom," a potential "Spider-Man" spinoff based on a bad guy.

The studio is developing the project, based on the gooey nemesis who appeared in "Spider-Man 3" and is hoping the character could dish up as an antidote to the ripening "Spider-Man" franchise in the way that Fox has used Wolverine to supply longevity to its "X-Men" franchise.

But getting any spinoff off the ground, let alone one centered on a baddie, can be tricky.

The studio had commissioned a potation of the script from Jacob Estes, a writer of the specialty film "Mean Creek," released various years ago by Paramount Classics. He's also attached to the Plan B drama "The Gifted."

But the studio is considering sledding in a different